Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 22nd Prioritisation – 1st quarter 2015. HSO: 22nd Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 22nd prioritisation (April 2015), 10 were filtered out of 180 identified drugs and were sent to prioritisation. Of these, 4 drugs were ranked as "highly relevant" by the expert panel, 4 as "relevant" and 2 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 22nd Prioritisation|
|Deposited on:||13 May 2015 13:00|
|Last Modified:||23 Aug 2017 12:40|
Repository Staff Only: item control page